Menu Close

Missouri University Partners With Israeli Startup To Foster Innovation

  • February 12, 2018

St. Louis, Missouri-based Washington University School of Medicine recently announced it signed a strategic partnership with Israel-based MDClone to connect data from across the BJC HealthCare system for use by researchers and clinicians.

The partnership will allow Washington University’s Institute for Informatics to develop new ways to use and share clinical data, and is MDClone’s first partnership outside of Israel.

“We will be able to make more of our data accessible to more researchers and collaborators than ever before, while simultaneously protecting patient privacy and confidentiality at a level that is unprecedented as compared to traditional approaches to data de-identification,” said Dr. Philip Payne, director of the Institute for Informatics.

Members of MDClone’s team traveled to Missouri to launch the partnership.

“We explored partnerships with leading institutions across the U.S. and have been impressed with the visionary leadership and top talent in healthcare delivery and research at Washington University in St. Louis,” said MDClone CEO Ziv Ofek. “This is a large deal for MDClone. But more than that, with this partnership, and the support of GlobalSTL and St. Louis’ robust healthcare ecosystem, we are uniquely positioned to continue developing a new healthcare data paradigm and introducing it across the U.S. and world.”

Cutting-edge biomedical research is taking place across Missouri, in world-renowned research hospitals, and innovation communities such as Cortex and the Missouri Innovation Center. And many of these companies are also leading the way with the latest in animal health research.

For more information on Missouri’s health innovation industry check out our webpage, or contact Steve Johnson, CEO of Missouri Partnership, at 314.725.2688 or via our contact form. He will answer any questions you might have, and explain how Missouri Partnership can help with your business expansion and investment needs.

What Next?